The most frequent non‐NK hILCs among intratumoral hILCs were group 1 ILCs comprising of 0.78% of CD45+ tumor‐infiltrating lymphocytes (TILs), followed by group 2 ILCs (0.54% of TILs), hNKp44+ILC3s (0.1% of TILs), and hNKp44− ILC3s (0.09% of TILs) (Figure 1A). Here, PTPRC is linked to neoplasm.